Inhibition of airway mucous hypersecretion by azithromycin through matrix metalloproteinase 9

National Medical Journal of China

Volumn 91, Issue 10, 2011, Pages 689-693

  Luo, Lin ^a   Perelman, Juliy M ^b   Kolosov, Victor P ^b   Zhou, Xiang Dong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

Azithromycin; Matrix metalloproteinase 9; Mucins

Indexed keywords

AZITHROMYCIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; GELATIN; GELATINASE B; LEUKOCYTE ELASTASE; MESSENGER RNA; MUCIN 5AC; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; GENETIC TRANSCRIPTION; MUCUS SECRETION; PROTEIN CONTENT; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; ZYMOGRAPHY; BRONCHUS; CELL CULTURE; CYTOLOGY; HUMAN; METABOLISM; RESPIRATORY TRACT MUCOSA; SECRETION;

AZITHROMYCIN; BRONCHI; CELLS, CULTURED; EPITHELIAL CELLS; HUMANS; MATRIX METALLOPROTEINASE 9; RESPIRATORY MUCOSA;

EID: 84869860066     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2011.10.011     Document Type: Article

References (8)

1. Cerveri I, Brusasco V. Revisited role for mucus hypersecretion in the pathogenesis of COPD. Eur Respir Rev, 2010, 19: 109-112.
2. Vempati P, Karagiannis ED, Popel AS. A biochemical model of matrix metalloproteinase 9 activation and inhibition. J Biol Chem, 2007, 282: 37585-37596.
3. Deshmukh HS, Shaver C, Case LM, et al. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am J Respir Cell Mol Biol, 2008, 38: 446-454.
4. Araujo FG, Slifer TL, Remington JS. Inhibition of secretion of interleukin-1 alpha and tumor necrosis factor alpha by the ketolide antibiotic telithromycin. Antimicrob Agents Chemother, 2002, 46: 3327-3330.
5. Shinkai M, Foster GH, Rubin BK. Macrolide antibiotics modulate ERK phosphorylation and IL-8 and GM-CSF production by human bronchial epithelial cells. Am J Physiol Lung Cell Mol Physiol, 2006, 290: L75-L85.
6. Ogawa M, Suzuki J, Takayama K, et al. Matrix metalloproteinase suppression induced by clarithromycin in murine cardiac allografts. Transplant Proc, 2009, 41: 395-397.
7. Ribeiro CM, Hurd H, Wu Y, et al. Azithromycin treatment alters gene expression in inflammatory, lipid metabolism, and cell cycle pathways in well-differentiated human airway epithelia. PLoS One, 2009, 4: e5806.
8. Imamura Y, Yanagihara K, Mizuta Y, et al. Azithromycin inhibits MUC5AC production induced by the Pseudomonas aeruginosa autoinducer N-(3-Oxododecanoyl) homoserine lactone in NCI-H292 Cells. Antimicrob Agents Chemother, 2004, 48: 3457-3461.